Ligand validation:2E56

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2E56 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2E56_NAG_A_801	41%	45%	0.1	0.812	0.56	1.52	-	3	0	0	100%	0.9333
2E56_NAG_A_901	4%	48%	0.166	0.551	0.66	1.32	-	3	0	0	100%	0.9333
3FXI_NAG_B_841	58%	56%	0.126	0.903	0.72	0.99	-	1	0	0	100%	0.9333
2Z65_NAG_A_1401	43%	50%	0.126	0.86	0.67	1.26	-	1	0	0	93%	0.9333
2E59_NAG_A_801	42%	48%	0.181	0.9	0.68	1.32	-	2	0	0	100%	0.9333
4G8A_NAG_D_201	23%	52%	0.255	0.876	0.52	1.33	-	1	0	0	100%	0.9333
3ULA_NAG_A_1201	13%	42%	0.192	0.727	1.1	1.14	1	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.